How Recent Pro-Preemption Wave May Lift Brand-Name Drugs
Recent and upcoming cases show the pharmaceutical preemption defense to be alive and well. In Wyeth v. Levine, the U.S. Supreme Court held that preemption for branded manufacturers hinged on their...To view the full article, register now.
Already a subscriber? Click here to view full article